fclitloan

More than 80 companies currently claim to offer manufacturing related services, at different scales of operations, for a variety of oligonucleotide-based products, claims Roots Analysis

Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios, building new capabilities and expanding their respective capacities, mostly through acquisitions, in order to gain a competitive edge.

The USD 5.8 billion (by 2030) financial opportunity within the has been analyzed across the following segments:

Type of manufacturing

Type of Oligonucleotides manufactured

Scale of operation

Purpose of production

Target therapeutic area

Size of manufacturer

Key Geographical Region

For more information, please visit

The Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030 report features the following companies, which we identified to be key players in this domain:

Table of Contents

For more information, please click on the following link:

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

About Roots Analysis

is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-delaoji.orgpth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com